987
The publishing house "Yuridychna Praktika" announced the twenty-first issue of Ukrainian Law Firms. A Handbook for Foreign Clients
560
At the invitation of the Verkhovna Rada Committee on Public Health, Medical Assistance and Medical Insurance, LA Law Firm's Managing Partner Dmytro Aleshko and Head of Intellectual Property Practice Vitalii Savchuk participated in a meeting on medicinal products affordability with representatives of the Association of Manufacturers of Medications of Ukraine.
806
The ranking study of the local market of legal services, published by Yuridychna Gazeta, covered 105 legal companies.
1251
This year's WWL: Life Sciences once again recognized LA Law Firm managing partner among the leaders.
571
On May 15-17, 2024, the Polish Investment and Trade Agency (Polska Agencja Inwestycji i Handlu – PAIH), along with its partners, hosted sectoral consultations a
1939
According to the results of the recently published international study The Legal 500 Europe, Middle East & Africa 2024 LA Law Firm is recognized among the leading law firms of Ukraine.
948
The research has announced the shortlist of the 2024 award winners, which includes partners and counsels of LA Law Firm in certain practices. The firm itself has been shortlisted in four categories.
1750
The national ranking features three partners and a counsel across four practice categories. Managing partner Dmytro Aleshko named among the TOP 100 legal practitioners in Ukraine and leaders in Medical Law / Pharmaceuticals.
1849
As soon as the pharmaceutical market began to recover from the adoption of the new List of OTC medicines prohibited for advertising, the Order of the Ministry of Health No. 1894 dated 02.11.2023 suspended its validity until 1 March 2024. In order to understand the legal implications of these developments, it is important to focus on certain aspects.
1518
On October 17, the MOH approved legislation requiring the international non-proprietary name of medicines to be indicated on paper and electronic prescriptions along with the mandatory indication of the form and dosage.
